AgeX Therapeutics, Inc. logo

AgeX Therapeutics, Inc.

AMEX:AGE

Overview | Financials
Company Name AgeX Therapeutics, Inc.
Symbol AGE
Currency USD
Price 0.43
Market Cap 16,326,649
Dividend Yield 0%
52-week-range 0.361 - 1
Industry Biotechnology
Sector Healthcare
CEO Dr. Joanne M. Hackett Ph.D.
Website https://www.agexinc.com

An error occurred while fetching data.

About AgeX Therapeutics, Inc.

AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as

Related Stocks

BiomX Inc. logo

BiomX Inc.

PHGE

0.41 USD

NanoViricides, Inc. logo

NanoViricides, Inc.

NNVC

1.1 USD

Timber Pharmaceuticals, Inc. logo

Timber Pharmaceuticals, Inc.

TMBR

1.461 USD

Financials

Numbers are in millions USD

Numbers are in millions USD